Literature DB >> 25403674

In vitro ceftriaxone susceptibility in methicillin-susceptible Staphylococcus aureus.

Kady Phe1, Dorothy Dao2, Hannah R Palmer3, Vincent H Tam4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25403674      PMCID: PMC4335838          DOI: 10.1128/AAC.04531-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureus.

Authors:  Brent W Wieland; Jodie R Marcantoni; Kerry M Bommarito; David K Warren; Jonas Marschall
Journal:  Clin Infect Dis       Date:  2011-12-05       Impact factor: 9.079

2.  Elevated Staphylococcus ceftriaxone MICs are an Etest artifact.

Authors:  Brandi M Limbago; Virginia M Pierce; David R Lonsway; Mary Jane Ferraro
Journal:  Clin Infect Dis       Date:  2014-09-28       Impact factor: 9.079

3.  Common Occurrence of Ceftriaxone-Resistant, Methicillin-Sensitive Staphylococcus aureus at a Community Teaching Hospital.

Authors: 
Journal:  Clin Infect Dis       Date:  2014-03-14       Impact factor: 9.079

4.  Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone.

Authors:  S A Winans; A M Luce; R Hasbun
Journal:  Infection       Date:  2013-05-19       Impact factor: 3.553

  4 in total
  3 in total

1.  Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus.

Authors:  Benjamin H Gern; Alexander L Greninger; Scott J Weissman; Jennifer R Stapp; Yue Tao; Xuan Qin
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-02-20       Impact factor: 3.944

2.  Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series.

Authors:  Rachel Amanda Lowe; Katie Elizabeth Barber; Jamie Leigh Wagner; Allison Miriam Bell-Harlan; Kayla Renay Stover
Journal:  J Pharmacol Pharmacother       Date:  2017 Jul-Sep

Review 3.  Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible Staphylococcus aureus (MSSA): A Systematic Review.

Authors:  Musaiwale M Kamfose; Francis G Muriithi; Thomas Knight; Daniel Lasserson; Gail Hayward
Journal:  Antibiotics (Basel)       Date:  2020-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.